EC Number   |
Expression |
Reference |
|---|
    5.3.99.2 | down |
L-PGDS knockout mice are generated |
705932 |
| 5.3.99.2 | down |
level of L-PGDS mRNA expression decreases as gastritis becomes more severe |
705307 |
| 5.3.99.2 | down |
lipopolysaccharide, LPS, reduces H-PGDS expression |
701618 |
| 5.3.99.2 | down |
oral pretreatment with the inhibitor EDJ300520 prevents the lipopolysaccharide-induced PGD2 increase in plasma and lungs |
705351 |
| 5.3.99.2 | up |
enzyme expression is increased in H2O2-treated neuronal cells |
726906 |
| 5.3.99.2 | up |
expression levels of L-PGDS mRNA and protein are significantly increased after 14 days of hypoxia |
702057 |
| 5.3.99.2 | up |
L-PGDS, but not H-PGDS, is induced on fibroblasts close to infiltrating cells in the Helicobacter pylori-infected gastric mucosa |
705307 |
| 5.3.99.2 | up |
mice lacking PPARgamma2 have elevated levels of lipocalin prostaglandin D synthase expression in brown adipose tissue and subcutaneous white adipose tissue |
-, 728575 |
| 5.3.99.2 | up |
the level of L-PGDS mRNA expression is increased 20fold in ulcerative colitis and increases with disease activity |
713720 |
| 5.3.99.2 | up |
the synthesis of PGD2 is increased in plasma and lungs in response to systemic lipopolysaccharide injection |
705351 |
